JP2000034264A - ４―（デス―ジメチルアミノ）―テトラサイクリンの製造方法 - Google Patents
４―（デス―ジメチルアミノ）―テトラサイクリンの製造方法Info
- Publication number
- JP2000034264A JP2000034264A JP11105105A JP10510599A JP2000034264A JP 2000034264 A JP2000034264 A JP 2000034264A JP 11105105 A JP11105105 A JP 11105105A JP 10510599 A JP10510599 A JP 10510599A JP 2000034264 A JP2000034264 A JP 2000034264A
- Authority
- JP
- Japan
- Prior art keywords
- tetracycline
- dimethylamino
- aqueous solution
- reaction
- des
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004098 Tetracycline Substances 0.000 title claims abstract description 36
- 229960002180 tetracycline Drugs 0.000 title claims abstract description 36
- 229930101283 tetracycline Natural products 0.000 title claims abstract description 21
- 235000019364 tetracycline Nutrition 0.000 title claims abstract description 21
- 150000003522 tetracyclines Chemical class 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 20
- 239000007864 aqueous solution Substances 0.000 claims abstract description 9
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003792 electrolyte Substances 0.000 claims abstract description 6
- 230000008569 process Effects 0.000 claims abstract description 6
- 230000009467 reduction Effects 0.000 claims abstract description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 42
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 8
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 239000001103 potassium chloride Substances 0.000 claims description 5
- 235000011164 potassium chloride Nutrition 0.000 claims description 5
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 4
- 229910052753 mercury Inorganic materials 0.000 claims description 4
- 229910052697 platinum Inorganic materials 0.000 claims description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims description 4
- 239000010935 stainless steel Substances 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 150000003863 ammonium salts Chemical class 0.000 claims 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 claims 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical group [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 238000002848 electrochemical method Methods 0.000 claims 1
- 235000007715 potassium iodide Nutrition 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 235000009518 sodium iodide Nutrition 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 15
- 239000000243 solution Substances 0.000 abstract description 14
- 150000001875 compounds Chemical class 0.000 abstract description 9
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 2
- 239000012022 methylating agents Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 11
- 239000011701 zinc Substances 0.000 description 11
- 229910052725 zinc Inorganic materials 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000012074 organic phase Substances 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 229940075397 calomel Drugs 0.000 description 2
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000005208 trialkylammonium group Chemical group 0.000 description 2
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/24—Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT102160 | 1998-05-26 | ||
| PT102160A PT102160B (pt) | 1998-05-26 | 1998-05-26 | Processo para a preparacao de 4-(des-dimetilamino)-tetraciclinas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000034264A true JP2000034264A (ja) | 2000-02-02 |
Family
ID=20085765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11105105A Pending JP2000034264A (ja) | 1998-05-26 | 1999-04-13 | ４―（デス―ジメチルアミノ）―テトラサイクリンの製造方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6143161A (enExample) |
| EP (1) | EP0962552B1 (enExample) |
| JP (1) | JP2000034264A (enExample) |
| KR (1) | KR19990087905A (enExample) |
| CN (1) | CN1192016C (enExample) |
| AT (1) | ATE213788T1 (enExample) |
| AU (1) | AU746608B2 (enExample) |
| CA (1) | CA2272598C (enExample) |
| DE (1) | DE69900927T2 (enExample) |
| ES (1) | ES2173706T3 (enExample) |
| HU (1) | HUP9900761A3 (enExample) |
| IL (1) | IL129244A (enExample) |
| IN (1) | IN192877B (enExample) |
| NO (1) | NO325059B1 (enExample) |
| NZ (1) | NZ334940A (enExample) |
| PT (1) | PT102160B (enExample) |
| ZA (1) | ZA992484B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101171408B1 (ko) | 2004-05-21 | 2012-08-08 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 테트라사이클린 및 이의 유사체의 합성 |
| JP5335664B2 (ja) * | 2006-04-07 | 2013-11-06 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | テトラサイクリンおよびその類似体の合成 |
| EP2479169B1 (en) | 2006-10-11 | 2014-12-03 | President and Fellows of Harvard College | Synthesis of Enone Intermediate |
| WO2010126607A2 (en) | 2009-04-30 | 2010-11-04 | President And Fellows Of Harvard College | Synthesis of tetracyclines and intermediates thereto |
| PT108978B (pt) | 2015-11-24 | 2020-03-09 | Hovione Farm S A | Sais de tetraciclinas |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1349043A (en) * | 1971-04-05 | 1974-03-27 | Pliva Pharm & Chem Works | Process for the preparation of 6-demethyl-6-deoxy-6-methylene tetracyclines |
| JP3016587B2 (ja) * | 1989-12-04 | 2000-03-06 | ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク | 非ステロイド抗炎症剤及びテトラサイクリンの配合 |
| US5308839A (en) * | 1989-12-04 | 1994-05-03 | The Research Foundation Of State University Of New York | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
| US5223248A (en) * | 1991-02-11 | 1993-06-29 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing antiplaque properties |
| CA2094874C (en) * | 1992-04-27 | 2003-02-11 | Thomas F. Mcnamara | Non-antibacterial tetracycline compositons possessing antiplaque properties |
| JPH069523A (ja) * | 1992-06-18 | 1994-01-18 | Kuraray Co Ltd | ４−デジメチルアミノテトラサイクリンの精製法 |
| JPH06256280A (ja) * | 1992-11-17 | 1994-09-13 | Univ New York State | 糖尿病における過度のコラーゲン架橋結合を阻害する非抗菌性化学修飾テトラサイクリンを含むテトラサイクリン |
| US5552297A (en) * | 1993-12-21 | 1996-09-03 | Abbott Laboratories | Lead detection method and reggents utilizing aminolevulinic acid dehydratase and tertiary phosphines |
| US5789395A (en) * | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
-
1998
- 1998-05-26 PT PT102160A patent/PT102160B/pt not_active IP Right Cessation
-
1999
- 1999-03-25 HU HU9900761A patent/HUP9900761A3/hu unknown
- 1999-03-26 AU AU22444/99A patent/AU746608B2/en not_active Ceased
- 1999-03-30 IL IL12924499A patent/IL129244A/xx not_active IP Right Cessation
- 1999-03-30 NZ NZ334940A patent/NZ334940A/xx unknown
- 1999-03-31 ZA ZA9902484A patent/ZA992484B/xx unknown
- 1999-04-01 EP EP99302600A patent/EP0962552B1/en not_active Expired - Lifetime
- 1999-04-01 ES ES99302600T patent/ES2173706T3/es not_active Expired - Lifetime
- 1999-04-01 DE DE69900927T patent/DE69900927T2/de not_active Expired - Lifetime
- 1999-04-01 AT AT99302600T patent/ATE213788T1/de active
- 1999-04-09 IN IN555DE1999 patent/IN192877B/en unknown
- 1999-04-09 KR KR1019990012481A patent/KR19990087905A/ko not_active Ceased
- 1999-04-13 JP JP11105105A patent/JP2000034264A/ja active Pending
- 1999-04-21 CN CNB991051548A patent/CN1192016C/zh not_active Expired - Fee Related
- 1999-04-29 NO NO19992072A patent/NO325059B1/no not_active IP Right Cessation
- 1999-05-21 CA CA002272598A patent/CA2272598C/en not_active Expired - Fee Related
- 1999-05-24 US US09/317,396 patent/US6143161A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL129244A0 (en) | 2000-02-17 |
| HUP9900761A3 (en) | 2000-06-28 |
| AU746608B2 (en) | 2002-05-02 |
| ZA992484B (en) | 1999-10-05 |
| ES2173706T3 (es) | 2002-10-16 |
| IL129244A (en) | 2003-01-12 |
| NO992072D0 (no) | 1999-04-29 |
| CA2272598C (en) | 2008-01-22 |
| HU9900761D0 (en) | 1999-05-28 |
| NZ334940A (en) | 2000-05-26 |
| NO325059B1 (no) | 2008-01-21 |
| PT102160A (pt) | 1999-11-30 |
| KR19990087905A (ko) | 1999-12-27 |
| IN192877B (enExample) | 2004-05-29 |
| NO992072L (no) | 1999-11-29 |
| EP0962552B1 (en) | 2002-02-27 |
| CN1192016C (zh) | 2005-03-09 |
| PT102160B (pt) | 2001-04-30 |
| CN1236775A (zh) | 1999-12-01 |
| ATE213788T1 (de) | 2002-03-15 |
| DE69900927D1 (de) | 2002-04-04 |
| EP0962552A1 (en) | 1999-12-08 |
| US6143161A (en) | 2000-11-07 |
| DE69900927T2 (de) | 2002-08-29 |
| AU2244499A (en) | 1999-12-02 |
| CA2272598A1 (en) | 1999-11-26 |
| HUP9900761A2 (hu) | 1999-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1926102B (zh) | N-保护的4-酮脯氨酸衍生物的制备方法 | |
| JP2003292484A (ja) | γ−ヒドロキシアミノ酸誘導体及びモナティン類の製造方法 | |
| DE3212170C2 (enExample) | ||
| EP0962552B1 (en) | A process for the preparation of 4-(des-dimethylamino)-tetracyclines | |
| BRPI0518958B1 (pt) | "método para produzir um derivado de biopterina, 1;2'-0- diacetil-l-biopterina e l-biopterina" | |
| FR2476094A1 (fr) | Procede electrochimique de deshydrogenation d'ethers de 3,5-enols steroides en conditions basiques pour donner des 4,6-dienones | |
| KR20050108376A (ko) | 시아노-이소벤조퓨란의 제조방법 | |
| PL167897B1 (pl) | Sposób wytwarzania czystej oksytetracykliny PL PL PL | |
| MXPA99003858A (es) | Un proceso para la preparacion de 4-(des-dimetilamino)-tetraciclinas | |
| JPH1067718A (ja) | ４−ヒドロキシアニリン類の製法 | |
| EP0539486B1 (fr) | Procede de preparation de derives de streptogramines | |
| JPS6053039B2 (ja) | Ｎ−アセチル／イラミン酸誘導体およびその製造方法 | |
| JP3888402B2 (ja) | 光学活性Ｎ−カルボベンゾキシ−ｔｅｒｔ−ロイシンの製造法 | |
| Sundberg et al. | Base-catalyzed formation and reactions of o-nitrophenylacetamides | |
| JPH0899942A (ja) | 置換ジアミノジカルボン酸誘導体の製造方法 | |
| JP2622115B2 (ja) | ベンジルアルコール類の製造方法 | |
| FI74949B (fi) | Framstaellningsfoerfarande foer 6-klor- -metyl-karbazol-2-aettiksyra. lisaeys patenttiin 71130 - tillaegg till patent 71130 | |
| JP3864996B2 (ja) | 新規なイミダゾピロロキノリン化合物 | |
| JPH02233692A (ja) | 新規なｎ↑６，２′―ｏ―ジ置換―アデノシン―３′，５′―環状リン酸及びその製法 | |
| IE61279B1 (en) | Process for the production of salts of aminomalonodinitrile | |
| JPH0143731B2 (enExample) | ||
| JPH0356482A (ja) | 光学活性な２―フタルイミドオキシーフェニル酢酸誘導体およびその製造方法 | |
| JPH01216962A (ja) | （±）−１−（４−ハロゲノフェニル）エチルアミンの光学分割方法 | |
| JPH0254827B2 (enExample) | ||
| JPH1095793A (ja) | 抗腫瘍性白金錯体カルボプラチンの製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050308 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050531 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050810 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050817 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060228 |